Huntington's disease (HD) is a hereditary progressive neurodegenerative disorder caused by a CAG repeat expansion in the gene coding for the protein huntingtin, resulting in a pathogenic expansion of the polyglutamine tract in the N-terminus of this protein. The HD pathology resulting from the mutation is most prominent in the striatal part of the basal ganglia, and progressive differential dysfunction and loss of striatal projection neurons and interneurons account for the progression of motor deficits seen in this disease. The present review summarizes current understanding regarding the progression in striatal neuron dysfunction and loss, based on studies both in human HD victims and in genetic mouse models of HD. We review evidence on early loss of inputs to striatum from cortex and thalamus, which may be the basis of the mild premanifest bradykinesia in HD, as well as on the subsequent loss of indirect pathway striatal projection neurons and their outputs to the external pallidal segment, which appears to be the basis of the chorea seen in early symptomatic HD. Later loss of direct pathway striatal projection neurons and their output to the internal pallidal segment account for the severe akinesia seen late in HD. Loss of parvalbuminergic striatal interneurons may contribute to the late dystonia and rigidity.
| INTRODUC TION
The most prominent neuropathology in HD occurs in the striatal part of the basal ganglia, in which progressive loss of projection neurons leads to severe striatal atrophy. 1 Although striatal projection neuron (SPN) loss is associated with the prominent motor symptoms as HD progresses, more subtle functional deficits are evident already in premanifest stages of HD. Premanifest HD individuals are impaired, for example, in the initiation and/or execution of motor tasks. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] As striatal neuron loss is minimal in premanifest HD, 1, 14, 15 early symptoms are likely to be largely driven by striatal neuron circuit level connectivity loss and dysfunction. Consistent with this, the early motor symptoms in premanifest HD develop in parallel with gradual loss of cerebral and striatal white matter, [16] [17] [18] [19] [20] [21] [22] [23] increasing striatal hypometabolism, 17, 24 and reduced striatal activation during behavioral tasks, 25, 26 all indicative of decreased cortical input to striatal neurons. Among the major sources of input to the striatum, shrinkage and eventually marked neuronal loss are seen in deep layers of the cerebral cortex that project to striatum and in cerebral white matter. [27] [28] [29] [30] Thalamus as well is a source of major input to striatum, and it shows substantial neuronal loss by late in disease. 27, 29, 30 Thus, in addition to the well-documented matrix. [31] [32] [33] The matrix is by far the larger of these 2 territories and is involved in motor control, while the patch neurons regulate midbrain dopamine neurons. As discussed in more detail below, SPNs in both striatal territories are affected in HD. Two major SPN types mediate the role of the matrix compartment in motor control, those rich in substance P (SP) but poor in enkephalin (ENK), and those rich in ENK and poor in SP. [31] [32] [33] The SP+ SPNs project to 2 different extrastriatal regions containing pallidal-type neurons that project to motor thalamus, the internal segment of globus pallidus (GPi), and the substantia nigra pars reticulata (SNr). 31, [34] [35] [36] [37] [38] [39] Because of this bisynaptic input to motor thalamus, the SP+ SPNs are commonly termed direct pathway SPNs, or dSPNs.
Of note, single-cell labeling studies in primates and rodents indicate that dSPNs projecting to GPi and SNr are largely separate populations, which nonetheless collateralize somewhat to each other's target. 36, 38, 39 In rodents, for example, GPi-preferring dSPNs project heavily to GPi and slightly to SNr, while SNr-preferring dSPNs project exclusively or nearly so to SNr. 36, 39 To further provide evidence for differences between these 2 dSPN types, we identified several GENSAT 40 lines that distinguish between the 2 different dSPN types, based on the labeling pat- 2 ). By contrast, the membrane-associated ring finger 4 (C3HC4)
line (also called BC056494) and the Avpr1b line appear to show selective EGFP expression in the striato-GPi/SNr dSPN type, as neuropil labeling is seen in both GPi and SNr but not in the axons F I G U R E 1 Images of matched sagittal levels for 4 different GENSAT lines (Rasgrp2, C3HC4, Drd1, and Drd2) that have GFP expression in different subsets of matrix SPNs. The images show striatum, GPe, GPi, SNc, and SNr in the single sagittal plane in all 4 cases, with GFP labeling of perikarya, axons, and terminals revealed by immunolabeling using diaminobenzidine (DAB) detection. Image A shows that labeling for the Rasgrp2 line is present minimally in terminals in GPe, but is present in axons passing through GPi and in terminals in the SNc and SNr neuropil. By contrast, image B for the C3HC4 mice shows some labeled terminals in the GPe neuropil and labeled terminals in the GPi, SNc, and SNr neuropil, but little labeling of axons passing through GPi. The Rasgrp2 mice thus appear to primarily have GFP labeling of striato-SNr matrix dSPNs, while the C3HC4 mice have GFP labeling in matrix dSPNs projecting to both GPi and SNr. Image C for Drd1 mice shows GFP labeling of both sets of dSPNs, as they have labeling in both the GPi neuropil and in axons passing through to the nigra. Image D for Drd2 mice shows labeling of iSPNs with terminal labeling confined to GPe and some in SNc. Figure 2 shows higher magnification views of GPe, GPi, and SNr for these 4 GENSAT lines. Images were taken from the GENSAT website passing through GPi (Figures 1 and 2 ). These findings further support a dichotomy of dSPNs into types that we will call striato-SNr and striato-GPi, which is further supported by the differential effect of HD on them, as discussed below. By contrast, several
other GENSAT lines such as the Drd1 and Chrm4 show labeling of both striato-SNr and striato-GPi dSPNs, because more matrix striatal neurons are EGFP+ than in any of the above 4 lines and labeling is present in the neuropil of both GPi and SNr and in the axons of passage traversing GPi on their way to SNr (Figures 1 and   2 ). Single-cell filling data 36, 39 and these 4 GENSAT lines indicate that striato-SNr dSPNs outnumber striato-GPi dSPNs in rodents, as would be expected from the relative sizes of GPe and GPi in rodents, 41 although they are likely to be more equal in numbers in primates given the more equal sizes of GPe and GPi in primates.
F I G U R E 2 High magnification views of GPe, GPi, and SNr from the sagittal views shown in Figure 1 . The images for the Rasgrp2 line (A-C) show the labeled axons largely passing through GPi (B) on their way to the nigra, while C3HC4 mice (D-F) have labeled terminals in the GPi neuropil, but little labeling of axons passing through GPi (E). The Drd1 mice (G-I) show GFP labeling of both sets of dSPNs, as they show labeling in both the GPi neuropil and in axons passing through to the nigra (H). Drd2 mice (J-L) show labeling of iSPNs with terminal labeling confined to GPe. Images were taken from the GENSAT website
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The ENK+ SPNs of the matrix compartment project to the external segment of globus pallidus (GPe). Because GPe itself proj- 2 ). The striatum also contains SPNs that project to SNc.
These neurons also are rich in SP, but some are rich in ENK as well. 31, 32 In rats, the striato-SNc projection has been reported to arise exclusively from neurons of the striatal patch compartment, 42 while in mice, a subset of neurons concentrated in the patch compartment but also present in the matrix compartment has been reported as the source of the striato-SNc projection. 43 The neurons of the striatal patch compartment and those SNc projecting neurons of the matrix appear to co-contain SP and ENK more commonly than is the case for dSPNs and iSPNs. 44 All SPNs share additional neurochemical features, but they differ in others that make it possible to distinguish dSPNs and iSPNs.
Because SPNs are GABAergic, they all express the enzymes that convert glutamate to GABA, namely the 65-kD and 67-kD forms of glutamic acid decarboxylase (GAD). 1, 31, 41 The perikarya of iSPNs and their terminals in GPe are also enriched in D2 dopamine and A2a adenosine receptors. [45] [46] [47] By contrast, the perikarya of striatoGPi dSPNs and their terminals in GPi are enriched in D1 dopamine receptors, as are the perikarya of striato-SNr dSPNs and their terminals in SNr. [45] [46] [47] Striato-SNc neurons tend to express mu opiate receptors, resulting in the patch compartment being defined by its enrichment in such receptors, 44 and coexpress D1 and D2 receptors. 48 All SPN perikarya and terminals also possess CB1-type cannabinoid receptors. [49] [50] [51] Their various neurochemical traits make it possible to study the progressive effect of HD on the SPN populations, either by studying the loss of labeled terminals in SPN target areas or by loss of labeled perikarya. The iSPNs and 2 dSPN types play different roles in movement control, and it is thus valuable to characterize how HD affects them to better understand HD pathophysiology. As summarized below, the data indicate that while SPNs as a class are highly vulnerable in HD, and as a result, SPN markers are lost from striatum as disease progresses, [52] [53] [54] iSPNs and striatoSNr dSPNs are lost more rapidly than are striato-GPi dSPNs in the human disease.
Immunohistochemical studies provided initial insight into the differential pattern of SPN loss in HD, indicating that ENK and GAD terminals in GPe, and SP and GAD terminals in the substantia nigra are lost sooner in the course of HD than are SP and GAD terminals in GPi (Figures 3-5 ). For example, depletion of ENK immunostaining F I G U R E 3 Images of immunohistochemically labeled sections showing GPi, GPe, and substantia nigra in control, grade 1 HD, and grade 3 HD cases, immunostained for SP in the case of GPi and the nigra and for ENK in the case of GPe. In the control, SP+ fibers abound in GPi, ENK+ fibers abound in GPe, and SP+ fibers abound in the nigra. In grade 1 HD, ENK+ fibers in GPe and SP+ fibers in the nigra are depleted, while SP+ fibers in GPi remain abundant. The contrast is even more evident in the grade 3 specimen, where ENK+ fibers are markedly depleted in the atrophied GPe and SP+ fibers in the nigra are sparse and patchy, but SP+ fibers in GPi are still quite prominent. This illustration is Figure 5 
| Striatal projection neuron abnormalities in animal models of HD
The studies of human HD striatal neuropathology establish the greater vulnerability of iSPNs than dSPNs, beginning early in HD progression, with the dSPNs projecting to GPi being especially resistant compared to the striato-SNr dSPNs. This feature of HD is then a hallmark neuropathology by which to judge the efficacy with which models of HD mimic the adult HD pathogenic process. Among the various rodent and large mammal models of HD, dSPN vs iSPN pathology has been most thoroughly assessed in mouse models, on which we will focus. In the case of the best-studied mouse model of HD, the mutant exon-1 transgene-expressing R6/2 mouse, PPE mRNA is decreased in symptomatic 6-and 12-week-old R6/2 mice, while striatal PPT mRNA expression is better preserved (Figure 6 ). 
91
We also found about a 20% decrease in ENK fiber staining in GPe F I G U R E 6 Images of coronal sections through rostral striatum labeled using in situ hybridization histochemistry, showing that striatal PPE mRNA levels but not PPT mRNA levels were reduced in R6/2 mice. Images of film autoradiograms for pairs of R6/2 and wild-type littermate mice at 3.5, 6, 8, and 12, weeks of age are shown. A large PPE mRNA reduction is evident in R6/2 mice at 6-12 weeks of age.
No PPT mRNA changes in R6/2 mice are obvious at any age. This illustration is Figure 1 from Sun et al. 91 Note that the autoradiographic analyses in this study were performed using radioactivity standards that allowed us to quantify the changes in PPE and PPT expression with age. This analysis showed PPE signal in WT declined from 3.5 to 6 weeks, but somewhat rebounded thereafter. In the case of PPT, signal was less at 6 and 8 weeks than at 3.5 weeks, but rebounded slightly at 12 weeks-see Figure 2 in Sun et al 
| Functional implications of differential vulnerability of striatal projection neurons and their outputs in HD
The early loss of iSPNs and their output to the GPe are thought to account for the chorea seen as the presenting symptom in adult-onset F I G U R E 7 Schematic illustrating the relative grade-wise loss of striato-GPe iSPNs and striato-GPi dSPNs in HD, and the relationship of this differential progression pattern to HD motor signs HD, according to the now standard direct-indirect pathway model of basal ganglia function ( Figure 7) . 61, 107, 108 The early loss of iSPN terminals in GPe was, in fact, part of the key early evidence in support of the model. 107 Given that each type of SPN is organized into microzones that interweave with other types within striatum, 109 The mutant rodent models provide an opportunity to examine the abnormal SPN physiology that may disrupt the output influence of striatum on its target areas prior to or during ongoing SPN loss and thereby contribute to pathophysiology. Many studies have reported increased excitability of SPNs in HD mouse models. 118 For example, Klapstein et al 119 reported that SPNs in R6/2 mice have depolarized resting membrane potentials, reduced inwardly rectifying potassium currents, and a lower threshold for action potentials by 12.5 weeks of age. Similarly, Rebec and co-workers have reported increased firing of SPNs in intact and awake 6-to 9-week-old R6/2 mice, but reduced burst firing and reduced synchronous firing. 120, 121 In vitro analysis has shown that the resting membrane potential of SPNs in Q175 mice also is more depolarized and more excitable as mice age. 122 These studies, however, have not clarified whether the increased excitability is true of both types of SPN.
119,121
Sebastianutto et al 123 recently examined the electrophysiological behavior of iSPNs in 2 of the mouse models showing greater iSPN than dSPN neurochemical pathology, namely 325CAG R6/2 mice and Q175 mice, with the HD mice crossed with a reporter line expressing EGFP in iSPNs (BAC-adora2a-eGFP) to allow identification of iSPNs during slice recordings in each model "before" and "after" the onset of motor deficits. In both models, iSPNs showed an early increase in excitability, driven by reduced inwardly rectifying potassium channel currents and a loss of primary dendrites. Following the onset of motor deficits, iSPNs in HD mice additionally showed loss of dendritic spines. Increased excitability of iSPNs predicts increased firing of these neurons in response to excitatory inputs in vivo. Note, however, as they did not examine dSPNs in this study, it is uncertain whether they do or do not show the enhanced excitability found in iSPNs. 123 Thus, while increased excitability and disrupted burst firing would interfere with striatal control of its target areas, it is uncertain whether the disruption differs between dSPNs and iSPNs and is a cause of any differential functional deficits in the direct and indirect striatal output pathways.
| Basis of differential striatal projection neuron vulnerability in HD
The attributes that make striato-GPi dSPNs more resistant than striato-GPe iSPNs, striato-SNr dSPNs, and striato-SNc neurons in showed that viral vector-driven expression of mutant huntingtin in dorsal striatum alone for 2 weeks produced parallel loss of dSPNs and iSPNs. They went on to show that the differential effect of HD on iSPNs and dSPNs appears driven from an action of the mutation on corticostriatal neurons. These findings will be discussed in more detail in the section below on evidence implicating disturbances in the cortical input to striatum in the genesis of differential SPN abnormalities. 119, [135] [136] [137] 140, [143] [144] [145] Of further interest regarding SPN pathogenesis is that striatal pathology is more prominent caudally than rostrally in early disease, and striatal degeneration proceeds, for yet unknown reasons, in a dorsomedial to ventrolateral direction. 146, 147 Consistent with this, shrinkage of the medially situated caudate is significant already 10 years from estimated disease onset, while shrinkage of the more laterally placed putamen is not significant until 3 years before estimated disease onset. 115 The basis of this regional difference in SPN vulnerability is uncertain, but it could be that the tendency of striato-SNr dSPNs to be more medially located in primates and striato-GPi dSPNs more laterally may account for the greater vulnerability of the former compared to the latter. Cholinergic interneurons represent 1%-2% of all striatal neurons in humans and nonhuman mammals and correspond to the tonically active striatal neurons detected in electrophysiological studies. [160] [161] [162] Cholinergic interneurons innervate both dSPNs and iSPNs and modulate SPN firing and reward-related (i.e, dopamine release related) plasticity at corticostriatal synapses. [161] [162] [163] Cholinergic interneurons exert differential effects on iSPNs and dSPNs in normal striatum, with cholinergic neuron activation increasing the responses of iSPNs relative to dSPNs to cortical drive. 162 Cholinergic striatal interneurons survive in intact numbers late into human HD, as well as in diverse animal models of HD. 63, 124, [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] 166 Blinded neuron counts confirmed that ChAT+ perikarya were normal in abundance, but size measurements showed they were significantly smaller. Sholl analysis revealed that the dendrites of Q140 ChAT+ interneurons were significantly fewer and shorter (Figure 8 ), and their paucity was confirmed by ultrastructural analysis. As the diminished dendritic branching was associated with decreased net excitatory input per interneuron, 166 as detailed in the section on thalamic inputs to interneurons, the thereby reduced excitatory drive is a likely contributor to reduced acetylcholine release from these neurons. Loss of excitatory drive would be predicted to more greatly lessen the responses of iSPNs than dSPNs to cortical drive, 162 which models of basal ganglia function predict should cause hyperkinesia. 107 As these defects in cholinergic neurons seem to be early occurring, they may contribute to the early hyperkinesia of adult-onset HD. Moreover, since striatal cholinergic interneurons express high levels of huntingtin, 143 these defects may be intrinsically driven by the mutation.
Note, however, that any cell autonomous effect of the huntingtin mutation on cholinergic interneurons is not lethal for the neurons, despite the high production of mutant protein. and iSPNs, and exert strong inhibitory control over SPNs. 181, [191] [192] [193] [194] Based on their connectivity and rapid cortical responses, FSIs are thought to inhibit striatal projection neurons in a feedforward manner as part of the process of switching from one movement to the next in a motor sequence. 195, 196 Two types of FSIs have been identified based on their responses to depolarizing current injection (continuous vs stutter firing) in rats and mice, although the stuttering type is less common in mice. 159 It is uncertain whether these 2 types have differential connectivity with dSPNs and iSPNs. Except for one study on R6/2 mice, 197 PARV striatal interneurons have consistently been reported as preserved in mouse HD models. 198, 199 F I G U R E 9 Camera lucida reconstructions of the distributions of neuropeptide Y-immunoreactive (NPY+) neurons at comparable levels of the basal ganglia in a normal juvenile (A), a choreic juvenile-onset HD grade 3 case (B), and a rigid juvenile-onset HD grade 4 case (C). Although the number of NPY-immunoreactive perikarya in putamen is similar for all 3 cases, shrinkage of the putamen greatly increases the packing density of these neurons in grade 3 and 4 HD. This illustration is Figure 2 
interneurons in human HD were limited but suggested that they may be lost from the striatum as HD progresses. 200, 201 Given the important role such loss could play in the progression of HD symptoms, we used immunolabeling for PARV in fixed sections to assess this issue in more detail. 202 In our study, we corrected for diseaserelated striatal atrophy by expressing PARV+ interneuron counts in ratio to interneurons cocontaining somatostatin and neuropeptide Y (whose numbers are unaffected in HD). At all symptomatic HD grades, PARV+ interneurons were reduced to <26% of normal abundance in rostral caudate. In rostral putamen, loss of PARV+ interneurons was more gradual, not dropping off to <20% of control until grade 2. Loss of PARV+ interneurons was even more gradual in motor putamen at globus pallidus levels, with no loss at grade 1, and steady grade-wise decline thereafter (Figure 10 ). Given the findings of some animal studies indicating that insufficient numbers of PARV+ striatal interneurons or their inactivation can cause dystonia, 185, 192, 203, 204 and given the grade-wise loss of PARV+ striatal interneurons in motor striatum in our human data in parallel with the grade-wise appearance and worsening of dystonia, our results raise the possibility that loss of PARV+ striatal interneurons is a significant contributor to dystonia in HD. Note, however, other studies in mice have reported that inactivation of striatal PARV interneurons does not cause dystonia, 205 and a 35% deficiency in PARV+ putamen interneurons was reported in Tourette syndrome patients without signs of dystonia. 206, 207 Moreover, studies of mutant mouse Dyt1 dystonia models have suggested that it is loss of striatal cholinergic interneurons that causes dystonia in those models, 208 although other researchers have not observed dystonia following selective ablation of striatal cholinergic interneurons.
209,210
Thus, the consequences of PARV interneuron loss for the pathophysiology of HD remain uncertain, as does the genesis of dystonia in later stages of HD.
CALR+ interneurons are GABAergic, possess medium-sized perikarya, and in rodents make up about 0.5% of all striatal neurons. 151, 154, 156, 211 In rodent studies, the CALR+ interneurons have been shown to receive excitatory input and appear to form terminals on SPNs. 154 In primate striatum, however, CALR+ neurons include both large and medium-sized neurons as well and make up about 7% of all neurons. 160, [212] [213] [214] [215] The vast majority of the large CALR+ neurons in normal human striatum coexpress ChAT and neurokinin-1 receptor (~90%) and thus represent cholinergic interneurons, 155, 213, 216, 217 with ~70% of striatal cholinergic neurons expressing CALR in humans 173 and about 30% in rhesus monkeys.
160
This may explain why the large CALR+ interneurons have been reported to survive well in HD, albeit with reduced ChAT expression, since as noted above cholinergic interneurons survive well in HD. 155, 173, 216 The medium-sized CALR+ interneurons of primate striatum appear to include both projection neurons and interneurons, with our studies in rhesus monkey indicating that CALR+ interneurons make up 1.5% of all striatal neurons and about 4% of SPNs being CALR+. 160 The presence of CALR+ projection neurons in rhesus is consistent with evidence showing that some mediumsized CALR+ neurons in humans possess spiny dendrites and thus appear to be SPNs. 155, 214 Note that medium-sized CALR neurons have also been reported to survive in HD. 216, 217 It would be of interest to know whether both CALR+ interneurons and the CALR+ SPNs survive, because this could provide insight into pathogenesis, particularly if the CALR+ SPNs constitute an HD-resistant subset of SPNs. Consistent with CALR+ interneuron survival in HD and a possible contribution to HD pathophysiology, striatal CALR expression is substantially increased in 3-to 6-month-old YAC128 mice. 198 
| S TRIATAL NEURON INPUT AB NORMALITIE S IN HD
The striatum receives its major inputs from cerebral cortex, thalamus, and the SNc. Each of these is affected during HD progression, particularly the excitatory cortical and thalamic inputs, and this is likely to have an effect on striatal neurons and thus basal ganglia function. The input from cerebral cortex, which arises from all cortical regions to a greater or lesser extent, is the more substantial of the 2 excitatory inputs and is thought to provide striatum with an instructive signal for its role in motor control. 82, 218 The thalamic input, which arises heavily from intralaminar, mediodorsal, and midline thalamic nuclei, 219, 220 however, also provides drive to striatum that is essential to its role in movement selection and facilitation.
162,221-223
The dopaminergic input from SNc is critical for the activity of dSPNs and iSPNs and their opposing roles in motor control. Abnormalities in cortical, thalamic, and dopaminergic input to each major striatal neuron type are reviewed below.
| Abnormalities in overall cortical input to striatum in human HD
Cerebral cortex undergoes neuron loss and shrinkage in HD, but more slowly and in the end less so than does striatum. 15, 27, [224] [225] [226] [227] The loss occurs mainly among pyramidal projection neurons in layers 3, 5, and 6, is evident over grades 2-4, and is prominent in grade underlie premanifest HD abnormalities. 247 We used VGLUT1 immunolabeling to detect corticostriatal terminals in dorsolateral (motor) striatum over the first year of life in these mice, prior to striatal projection neuron pathology. We found that VGLUT1+ axospinous corticostriatal terminals represented about 55% of all excitatory synaptic terminals in striatum, with thalamic axospinous terminals accounting for the remainder of axospinous terminals (about 35%
| Abnormalities in cortical input to striatal projection neurons in humans and mutant mouse models of HD
of all excitatory synaptic terminals in striatum). Many fewer cortical terminals ended on dendrites (about 5% of all cortical terminals in mice). In Q140 mice, VGLUT1+ axospinous and axodendritic terminals were reduced by 30% at 12 months (Figure 11 ), but showed no The corticostriatal input arises from 2 neuron types, an intratelencephalically projecting (IT) type residing predominantly in layer III and upper layer V, and a pyramidal tract (PT) type located primarily in lower layer V. [254] [255] [256] [257] [258] [259] [260] [261] [262] We and other investigators have found in rats and monkeys that PT-type corticostriatal neurons preferentially contact striatal neurons projecting to GPe with larger terminals, while IT-type cortical neurons preferentially target striatal neurons projecting to GPi or SNr with smaller terminals (Figure 12 ). [263] [264] [265] [266] In our study in 12-month-old Q140 mice, the loss of corticostriatal terminals occurred selectively for smaller terminals, suggesting they might be IT-type terminals and preferentially lost from direct pathway type striatal neurons. 247 If this was the case, this loss of drive to the "go"
neurons of the direct pathway would be expected to cause behavioral hypoactivity, which is observed as a major symptom as Q140 mice age. 90, 267, 268 To directly assess the loss of corticostriatal terminals from dSPNs vs iSPNs, we performed double immunolabeling to identify corticostriatal (VGLUT1+) axospinous terminals and D1 receptor immunolabeling to distinguish dSPN (D1+) and iSPN (D1−) synaptic targets and examined tissue at the electron microscopic (EM) level. 269 We found that the loss of corticostriatal terminals at 12 months of age was preferential for D1+ spines and especially in- The basis of the selective reduction in cortical terminals on dSPNs as HD symptoms progress is uncertain. In R6/2, Q175, and YAC128
HD mice, the loss in corticostriatal drive to the striatum is preceded by earlier corticostriatal hyperactivity. 121, 248, 251, 270, 271 The dSPNs in particular show early enhanced and later reduced corticostriatal excitation. 253, 270, 272 The reduced corticostriatal excitation appears to reflect the loss of corticostriatal input rather than reduced striatal excitability, because dSPNs remain more depolarized at rest and have elevated membrane input resistances. 248, 252, 273 The preferential loss of cortical input to dSPNs we observed is of interest in light of the possibility that the loss is neuroprotective. The dSPNs projecting to
GPi are the most resistant striatal projection neuron type in HD, 61 and a downregulation in excitatory cortical input to them could F I G U R E 1 2 Schematic illustration of the relative abundances of axospinous IT-type and PT-type inputs to dSPNs and iSPNs. Both dSPNs and iSPNs receive axospinous IT-type and PT-type inputs, with dSPNs receiving about twice as much IT-type and iSPNs receiving twice as much PT-type axospinous input. Note that, as depicted, PT-type axospinous terminals are uniformly larger than IT-type axospinous terminals, and IT-type axospinous terminals on iSPNs are slightly larger than IT-type axospinous terminals on dSPNs. This illustration is Figure 4 from Deng et al 264 help explain not only why striato-GPi dSPNs resist death better in human HD than do other striatal SPN types, but also may explain the emergence of resistance to corticostriatal excitotoxicity as HD mice age. 250, 274, 275 The corticostriatal synaptic pruning may, thus, involve activity-dependent mechanisms, rather than an HD-driven cortical pathology selective for the cortical input to dSPNs. 276, 277 Stevens and co-workers have suggested, on the other hand, that the corticostriatal pruning represents a complement-mediated process involving microglial removal of defective corticostriatal terminals, with the mutation acting both pre-and postsynaptically to cause corticostriatal terminal defects and a process engendering their removal. 278, 279 They also report that rescuing the terminals from microglial pruning by interfering with complement function reduces HD functional deficits. Foster et al, 280 however, reported findings that appear to suggest that elimination of defective corticostriatal terminals improves motor performance in Q175 mice. Further studies are thus needed to determine the mechanisms underlying the pruning of corticostriatal terminals in HD and the therapeutic value of preventing their pruning without additionally taking measures to mitigate the potentially excitotoxic consequences of SPN hyperexcitability.
Prior to corticostriatal terminal loss, dysfunction in the corticostriatal input may contribute to disturbed SPN function, as well as to pathogenesis. Studies in mouse models have shown earlier and more prominent electrophysiological abnormalities in the cortical input to iSPNs than to dSPNs. For example, evoked glutamate currents in BACHD and YAC128 mice were found to be larger in iSPNs than dSPNs. 270, 272 Moreover, iSPNs but not dSPNs show early deficits in corticostriatal synaptic plasticity in BACHD mice, and an earlier increase in extrasynaptic GluN2B NMDA receptor subunits. 281 The defects in iSPN corticostriatal plasticity appear to stem from defective BDNF-TrkB signaling in iSPNs. 281 These findings on TrkB involvement are of interest in light of the evidence that normal huntingtin promotes BDNF production by cortical neurons but polyglutamine-expanded huntingtin promotes BDNF production less effectively, and accordingly cortical BDNF production is reduced in human HD and in transgenic HD mice. [139] [140] [141] 282, 283 TrkB on striatal neurons also appears to be reduced by the HD mutation in humans and mice, 139, 141, 284 and accordingly, TrkB signaling by striatal neurons is reduced. 285 For these reasons, considerable attention has focused on the possibly important role of diminished corticostriatal BDNF signaling in the pathogenesis of striatal injury in HD. The iSPNs seem especially dependent on BDNF signaling, as embryonic deletion of the BDNF receptor (TrkB) from striatal neurons or hemizygous knockout of BDNF in R6/1 mice results in the preferential reduction in iSPNs. 95, 286 Moreover, BDNF overexpression rescues iSPNs in YAC128 mice, 99 and drugs that boost cortical BDNF production appear to rescue iSPNs in proportion to the boost in BDNF production ( Figure 14) . 136 In this regard, it is also of interest to note that BDNF production by the type of neuron whose axospinous input to dSPNs that we have shown appears to be preferentially lost in Q140 mice (i.e, the IT-type) 269 appears to be less than for PT-type corticostriatal neurons, 287 which are the preferential source of axospinous input to iSPNs. [264] [265] [266] A particular role of diminished corticostriatal BDNF signaling in iSPNs may explain why presynaptic CB1
receptors on corticostriatal terminals can protect dSPNs against the excitotoxic effects of the HD mutation but not iSPNs. 137 The possible existence of differing pathogenic mechanisms for iSPNs and dSPNs (BDNF deprivation for iSPNs and excitotoxicity for dSPNs)
could help explain why they are differentially affected in HD.
Corticostriatal neurons themselves show reduced inhibition
and increased activation in symptomatic R6/2, Q140, and YAC128
mice. 288, 289 To better understand corticostriatal abnormalities in HD, it would also be useful to know whether HD differentially affects the 2 types of corticostriatal neurons, the IT-type and the PT-type, [264] [265] [266] and their synapse formation with their striatal target neurons. For example, it could be the case that the HD mutation more greatly affects the behavior of IT-type neurons, rendering them more active than PT-type neurons, which ultimately then leads to the preferential loss of IT-type terminals from dSPN spines.
| Abnormalities in cortical input to striatal interneurons in humans and mutant mouse models of HD
Far less is known about abnormalities in the cortical input to striatal interneurons, and most of what is known comes from studies
Graphs showing the size frequency distributions for VGLUT1+ axospinous synaptic terminals on D1+ (A) and D1− (B) SPNs in striatum of 12 month-old WT and heterozygous Q140 male mice. D1+ spines belong largely to dSPNs and D1− spines to iSPNs. Note that the large shortfall in small terminals on D1+ spines (i.e, dSPNs) in Q140 mice. This illustration is Figure rons. Anatomical studies suggest that the excitatory input to cholinergic interneurons arises more from thalamus than cortex, 222, 292, 293 and as discussed in the next section, thalamic input to cholinergic interneurons is reduced early in the lifespan of heterozygous Q140
mice, 166 and thalamic responses are reduced in cholinergic interneurons in young heterozygous Q175 mice. 294 The striatal LTS interneurons receive a weak cortical input and have a modulatory somatostatinergic influence and a weak GABAergic inhibitory effect on SPNs. 182 Although LTS interneurons are resistant in HD and survive undiminished late into disease, 164, 167, 169, 172 expression of NOS and somatostatin in these neurons is progressively diminished. 174 Nonetheless, LTS+ neurons in at least some mouse HD models (R6/2 and BACHD) have been shown to be more spontaneously active than normal, but SPN responses to activation of LTS interneurons in these models was, nonetheless, normal. 187 Although LTS neurons receive some limited cortical input, 295 they appear to modulate SPNs in a cortical inputdependent manner. 
| Abnormalities in overall thalamic input to striatum in humans and mutant mouse models of HD
The striatum also receives a substantial excitatory input from the thalamus, which ends in large part on the spines and dendrites of SPNs, with cholinergic interneurons being a prominent target as well. 222, 246, 292, 293 The thalamic projection is topographically organized and arises heavily from the intralaminar nuclei, 219,220 but also from specific sensory nuclei of the thalamus. The intralaminar thalamic nuclei projecting to striatum receive polysensory cortical and brainstem input and a feedback projection from GPi. By the topographically ordered polysensory input, the intralaminar thalamus detects diverse behaviorally relevant events and serves to signal the neurons in the appropriate part of striatum of this behaviorally relevant event. Accordingly, the thalamic input is thought to play a role in attentional mechanisms involved in motor planning and preparedness. 162, [221] [222] [223] The intralaminar nuclei show differing evolutionary elaborations in primates and rodents, with the main intralaminar nuclei in primates being the more laterally situated centromedian and the more medially situated parafascicular nucleus. In rodents, the medial part of the parafascicular nucleus corresponds to the F I G U R E 1 4 Graph showing the relationship between M1 motor cortex layer 5 BDNF neuron abundance and the abundance of striatal ENK neurons. For these graphs, all WT mice are pooled (i.e, vehicle-treated and LY379268-treated together) as a group, and all R6/2 are pooled (i.e, vehicle-treated and LY379268-treated together) as a group, because trends were similar irrespective of drug treatment. Note that ENK neuron abundance in R6/2 mice is significantly and positively correlated with cortical layer 5 BDNF neuron abundance (r = 0.4299). This illustration is Figure 5 from Reiner et al, 136 in which we showed that daily LY379268 treatment increased cortical BDNF and mitigated deficits and pathology in R6/2 mice primate parafascicular nucleus and the lateral part of the rodent parafascicular nucleus corresponds to the primate centromedian. 222, 296 Additional nuclei, however, are also part of the intralaminar complex that targets striatum, and they are divergent among mammals in name and number. Importantly, there appear to be variations among the intralaminar nuclei in their targeting of striatal neurons as well as their spiking characteristics, and thus, perhaps functional differences may exist among them. For example, parafascicular/ centromedian terminals in rats and monkeys have been reported to preferentially contact dendrites, while terminals arising from the other intralaminar nuclei have been reported to favor spines. [297] [298] [299] [300] Moreover, parafascicular neurons in rodents have been observed to differ in their firing properties from other intralaminar nuclei. 297 The thalamus, including the intralaminar nuclei, undergoes shrinkage and cell loss in human HD. 15, [301] [302] [303] The centromedian, for example, shows evident neuronal loss by grade 3, 147 and together the centromedian/parafascicular nuclear complex shows about a 25%
volume loss and 50% neuron loss in advanced HD, 304 while only 15%
neuron and volume loss are seen in the mediodorsal nucleus of the intralaminar thalamus. 305 Various morphological and neurochemical abnormalities have also been observed in intralaminar thalamus in mouse models of HD, including increased GFAP expression, loss of the adhesion molecule tenascin-C, and loss of the synaptic protein complexin II. 306, 307 Given the role of thalamic input to the striatum in attentional mechanisms concerning motor planning and preparedness, 222 the HD-related neuronal loss, shrinkage, and pathology in intralaminar thalamus are likely to be associated with loss of thalamic input to striatum. This loss and the possible dysfunction preceding it are likely to be significant contributors to HD symptoms, particularly if there is a neuron-type specific pattern to the loss. As in the case of the corticostriatal input, however, data from human HD on the neuron-type specificity of the thalamic input loss and dysfunction is limited, and insight is mainly provided by mouse models.
| Abnormalities in thalamic input to striatal projection neurons in humans and mutant mouse models of HD
To address the likely loss of thalamic input to SPNs in human HD, especially as it might occur prior to striatal neuron loss or clinically evident motor symptoms, we carried out CLSM imaging studies and electron microscopic ultrastructural studies in male heterozygous Q140 HD knock-in mice. 247 We used VGLUT2 immunolabeling to detect thalamostriatal terminals in dorsolateral (motor) striatum over the first year of life, prior to striatal projection neuron pathol- could contribute to neurodegeneration of iSPNs in particular, due to their apparent particular dependence on BDNF.
Although the thalamic input to striatum targets both dSPNs and iSPNs, in primates and rats the input seems preferential for dSPNs, 296, 299, 311, 312 but not in mouse. 292 Additionally, the response of iSPNs to thalamic terminal activation differs from that for dSPNs, with iSPN responses more rapid and less sustained. 295 To determine whether loss of thalamic input might differ between dSPNs and iSPNs and thus differentially affect HD pathophysiology, we carried out ultrastructural double-label studies in male heterozygous Q140 mice, using immunolabeling to identify thalamostriatal (VGLUT2+) axospinous terminals, and D1 receptor immunolabeling to distinguish dSPN (D1+) and iSPN (D1−) synaptic targets (Deng et al 269 ). We found that the thalamostriatal terminal loss was comparable for D1+
and D1− spines at both 4 and 12 months. Thus, although dSPNs have been reported to receive a greater thalamic input than iSPNs in rats and monkeys, 296, 299, 312 no differential loss of thalamic input to SPNs was seen in our study of Q140 mice. Similar to Q140 mice, nondifferential thalamic terminal loss at D1/D2 spines was also reported in R6/2 mice by Parievsky et al. 309 The finding that the deficiency in thalamostriatal axospinous terminals in Q140 mice is present already at 1 month of age suggests it may represent a development defect. Consistent with this, striatal expression of proteins critical to thalamostriatal synapse formation, such as the semaphorin-3E receptor Plexin-D1 signaling complex, is significantly reduced early in the lifespan of several transgenic or knock-in HD mice, 313, 314 and in human HD as well. 315 In any case, the impoverishment of thalamic excitatory drive to striatum may help explain early motor defects in Q140 mice and in premanifest HD. Because of the low membrane excitability of SPNs, only temporally correlated excitatory input from a sufficiently large number of convergent excitatory inputs can depolarize SPNs to firing threshold. 218, 246, [316] [317] [318] [319] Part of the needed activation may derive from the cortical inputs, but the attention-related thalamic input may serve to ensure that the striatal neurons activated are those that drive the response appropriate to that environmental circumstance. This may be particularly true for dSPNs, which play a role in movement facilitation. 107, 320 For any given striatal territory, the intermingled dSPNs and iSPNs play opposite roles in movement, with the direct facilitating desired and the indirect opposing unwanted movement. Thus, as for the input from any given part of cortex to any given part of striatum, the inputs to these 2 SPN types may arise preferentially from different thalamic neuron types. In this regard, it would be of interest to know whether there are differing types of thalamostriatal projection neurons and whether they F I G U R E 1 5 Graphs showing the size frequency distributions for VGLUT2+ thalamostriatal axospinous synaptic terminals in striatum of 1-month-(A), 4-month-(B), and 12 month-old (C) wild-type and heterozygous Q140 Huntington knock-in male mice. Note that a shortfall in small terminals was found in Q140 mice at 1, 4 months, and 12 months. This illustration is Figure 9 from Deng et al consists of neuronal subtypes, as axonal reconstructions show that some of its neurons innervate cortex only, some striatum only, and some both. 321 Moreover, neurons of the centromedian/parafascicular complex in primates have been divided into subtypes based on their responses to sensory stimuli, with some displaying shortlatency activation and others displaying long-latency activation.
322
These 2 populations are segregated in the centromedian/parafascicular complex of primates, with the short-latency neurons predominantly found in the parafascicular nucleus and the long-latency neurons in the centromedian nucleus. 322 As noted above, the various intralaminar nuclei in rodents differ in the extent to which they target spines vs dendrites of striatal neurons, and they also differ in their perikaryal morphology and striatal arborization patterns. the thalamus is the major source of excitatory input to cholinergic interneurons in striatum in rodents and primates 222, 292, 293, 325 (and drives striatal acetylcholine release), 326 we assessed whether there are changes in the VGLUT2 immunolabeled thalamic input to striatal cholinergic interneurons in heterozygous Q140 males at 1 and 4 months of age, using ChAT immunolabeling to identify cholinergic interneurons. 166 Although blinded neuron counts showed that ChAT perikarya were normal in abundance in Q140 mice, the dendrites of Q140 ChAT interneurons were significantly fewer and shorter as early as 1 month of age, and individual ChAT interneurons as a consequence were likely to be contacted by fewer VGLUT2 thalamostriatal axodendritic terminals. 247 These results show that the abundance of thalamic input to individual striatal cholinergic interneurons is reduced early in the lifespan of Q140 mice, raising the possibility that this may occur in human HD as well. Consistent with our findings, Tanimura et al 294 reported reduced thalamic responsiveness in striatal cholinergic interneurons in R6/2 mice, and Holley et al 177 reported enhanced inhibitory input to them, both of which would reduce their activity. As cholinergic interneurons differentially affect F I G U R E 1 6 Time line of major changes in striatal projection neurons and interneurons and their inputs during HD progression, as they relate to the appearance of the major motor symptoms in adult-onset HD. Note that in the case of juvenile HD, progression is very rapid, SPN loss appears to be nondifferential, and dystonia and rigidity are the presenting symptoms dSPNs and iSPNs, 162 their reduced activation, especially by the thalamic input mediating attentional processes, may contribute to early abnormalities in movement onset and switching in HD in response to a changing stimulus context. 326 No published information from studies of mouse models is available on how HD may affect thalamic inputs to the other striatal interneuron types, of which the parvalbuminergic interneurons and LTS interneurons but not calretininergic interneurons have been shown to receive and respond to thalamic input in rodents and/or primates. Neuropathological studies, nonetheless, show that the substantia nigra undergoes cell loss and shrinkage in HD, but much less so than the striatum. 15, 27, 224, 328 Shrinkage of substantia nigra as detected in imaging studies also has been reported, which could stem from both dSPN input loss and nigral neuron death. 301 Loss of both
SNr GABAergic neurons and SNc dopaminergic neurons is evident
in HD, 147 and Oyanagi et al 329 that tyrosine hydroxylase protein in the nigra was reduced by 32%.
As would be predicted from loss of nigral dopaminergic neurons and reduced tyrosine hydroxylase expression, terminals containing tyrosine hydroxylase appear to be reduced in abundance in advanced HD striatum. 331, 332 Dopamine, homovanillic acid (HVA), the dopamine transporter (DAT), and the vesicular monoamine transporter-2 (VMAT2) also have been reported to be reduced in HD striatum in later disease stages. 290, [333] [334] [335] Nonetheless, increases in dopamine have actually been observed early in disease. 336 Late loss of dopamine input could contribute to akinesia in HD, as it does in Parkinson's disease, while early increases could synergize with iSPN loss and dysfunction to exacerbate hyperkinesia. In the later regard, it is interesting to note that L-DOPA provokes hyperkinesia in otherwise asymptomatic HD carriers. 
| Abnormalities in overall nigral input to striatal projection neurons in humans and mutant mouse models of HD
As the dopaminergic input to striatum heavily targets SPNs, 41 the apparent biphasic change in dopaminergic input to them may contribute to HD pathophysiology in humans. 343 Although no specific data are available for human HD on the extent to which the early increase in DA release and later loss of dopamine input may be preferential for either SPN type, even equal early increase and late loss would have differential effects on motor function due to the opposing actions of dopamine on iSPNs and dSPNs. 82 For ex- 
| SUMMARY AND CON CLUS I ON S
The pathophysiology of motor impairment in HD involves dysfunction and loss of striatal projection neurons (Figure 16 ). Dysfunction occurs early and stems from a loss of cortical and thalamic inputs to SPNs, abnormalities in their inputs from striatal interneurons, and dysregulation of intrinsic SPN neuronal excitability. Actions of the mutant protein on the neurons projecting to SPNs and on SPNs themselves are likely to contribute to the SPN dysfunction, which accounts for the early mild symptoms of HD such as motor slowing.
By contrast, the later loss of SPNs and their outputs to GPe, GPi,
and SNr is associated with the clinically prominent motor abnormalities of HD. More rapid loss of iSPNs projecting to GPe than dSPNs projecting to GPi accounts for early chorea that is gradually overlain with bradykinesia as striato-GPi dSPN loss approximates iSPN loss.
A greater vulnerability of iSPNs than dSPNs to BDNF deprivation stemming from reduced cortical production and delivery appears to account for the earlier and greater vulnerability of iSPNs. The basis of the emergence of dystonia late in HD is uncertain, but may relate to the late loss of striatal PARV interneurons, as well as to the then extensive dSPN loss. 345 The extent to which slowing or preventing early input loss and/or correcting early dysregulation of SPN intrinsic excitability would mitigate early deficits and slow progression to SPN neuron and output loss remains to be determined, but insights into this could provide clues for pathogenesis and treatment approaches.
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